Human genome project(ibri)


Published on

Published in: Education
No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Human genome project(ibri)

  1. 1. Abhinav Srivastava, Ph.DDirectorIndian Biosciences and Research InstituteC-50, Sector-02, NOIDA-201310, Uttar Pradesh email:
  3. 3. GENOMEThe hereditary material of all multi-cellularorganisms is the famous double helix ofdeoxyribonucleic acid (DNA), which contains all ofour genes.
  4. 4. All our genes together are known as“GENOME”.The entire genetic makeupof the human cell nucleus.
  6. 6. HUMAN GENOME PROJECT The Human Genome Project (HGP) was the international, collaborative research program whose goal was the complete mapping and understanding of all the genes of human beings. Genes carry the information for making all of the proteins required by the body for growth and maintenance. Made up of ~35,000-50,000 genes which code for functional proteins in the body.
  7. 7. GOAL OF HGP Identify all of the genes in human DNA. Determine the sequence of the 3 billion chemical nucleotide bases that make up human DNA. Store this information in data bases. Develop faster, more efficient sequencing technologies.
  8. 8. GOAL OF HGP : Develop tools for data analysis. Address the ethical, legal, and social issues (ELSI) associated with the project.
  9. 9. Two Different Groups W orked to Obtain the DNA Sequence of the Human Genome The HGP is a multinational consortium established by government research agencies and funded publicly. Celera Genomics is a private company whose former CEO, J. Craig Venter, ran an independent sequencing project. June 6, 2000, the HGP and Celera Genomics held a joint press conference to announce that TOGETHER they had completed ~97% of the human genome.
  10. 10. PUBLICATION The International Human Genome Sequencing Consortium published their results in Nature, 409 (6822): 860-921, 2001. “Initial Sequencing and Analysis of the Human Genome” Celera Genomics published their results in Science, Vol 291(5507): 1304-1351, 2001. “The Sequence of the Human Genome”
  12. 12. STRATEGY INVOLVED This is regarded as the most ambitious project ever undertaken by man. Strategy may be grouped into following three stages: i) Mapping ii) Sequencing iii) Functional analysis
  13. 13. MAPPING The first major goal of the project is to prepare high resolution or saturated genetic and physical maps of human genome. Molecular markers have been used to produce maps of all the human chromosome. By August 2000, over 9,300 markers had been mapped to particular chromosome. Therefore, any new DNA sequence (i.e., an additional marker) can be easily linked with these markers.
  14. 14. SEQUENCING Determination of precise order of nucleotide in DNA. There are following techniques for the DNA sequencing: i) Chain termination method By F.Sanger & A. R. Coulson ii) Chemical degradation method By A. Maxam & W. Gilbert iii) Automated DNA sequencing
  15. 15. CHAIN TERMINATIONMETHOD Nucleotide analogs (called dideoxynucleotides or ddNTP) are incorporated into DNA during its synthesis together with normal nucleotides (called deoxynucleotides or dNTP). When a ddNTP is inserted, the reaction stops = chain termination. Four different reactions are performed. Each reaction contains either ddA, ddG, ddC, or ddT. Autoradiography enable analysis of different fragment lengths which correspond to different
  16. 16. CHEMICAL DEGRADATIONMETHOD Double stranded DNA fragment to be sequenced is first labeled by attaching a radioactive phosphorous group to the 5’end of each strand. DMSO then added and the sample heated to 90°C, degraded sample is allowed for GE. One strand is purified from gel & divided into foru sample each of which is treated with one of the CLEAVAGE REAGENT. The first set of reagent to be added cause a chemical modification in the nucleotide for which they are specific, making the strand susceptible to cleavage at that nucleotide when an additional chemical is added.
  17. 17. AUTOMATED DNASEQUENCING This is carried out in the same way as the chain termination method with only one difference. Here we use FLUORESCENT LABELS to label the strand instead of radioactive label. These labels are usually attached to the ddNTP so each chain terminated molecule carries a single label at its 3’end. Different fluorochrome can be used for four different ddNTP.
  18. 18. FUNCTIONAL ANALYSIS The ultimate objective of the HGPis to decipher the function of each of the genes estimated to be present in the human genome.
  20. 20. MICROBIAL GENOME Ha e m o p hilus influe nz a e Es c he ric hia c o li Ba c illus s ubtilus He lic o ba c te r p y lo ri Stre p to c o c c us p ne um o nia e AND MANY MORE !
  21. 21. PLANT GENOME A bid o p s is tha lia na ra
  22. 22. INSECT GENOME Dro s o p hila m e la no g a s te r
  23. 23. RODENT GENOME M m us c ulus us
  25. 25.  The U.S. Department of Energy (DOE) and the National Institutes of Health (NIH) spend between 3-5% of their annual HGP budgets toward studying the ELSI associated with availability of genetic information. This budget is the world’s largest bioethics program, and has become a worldwide model.
  26. 26. EXAMPLE OF ELSI Privacy legislation Gene testing Patenting Forensics Behavioral Genetics Genetics in the Courtroom
  27. 27.  Who should have access to this information ?  Employers  Insurers  Schools  Courts  Adoption agencies  Military
  28. 28.  How is privacy and confidentiality managed ? Affects on society’s perceptions and expectations of the individual Who owns genes and DNA sequences ?  The person (or company) who discovered it, or the person whose body it came from?  Should genetic information be the property of humanity?  Is it ethical to charge someone for access to a database of genetic information?
  29. 29. APPLICATIONW hich branches ofbiology will benefit fromthis knowledge ?
  30. 30. MEDICINE Improvements in diagnostic and therapeutic applications Implementation of preventative measures. Increases in gene therapy applications.
  31. 31. BIOTECHNOLOGY Production of useful protein products for use in medicine, agriculture, bioremediation and pharmaceutical industries.  Antibiotics  Protein replacement (factor VIII, TPA, streptokinase, insulin, interferon…)  BT insecticide toxin (from Ba c illus thuring ie ns is )  Herbicide resistance (glyphosate resistance)  Bioengineered foods [e.g. Flavr Savr tomato (antisense – polygalacturonase) to delay rotting]
  32. 32. BIOINFORMATICS The newest, fastest growing specialty in the life sciences that integrates biotechnology and computer science. Involved in DNA sequence assembly and analysis using computer-based techniques to determine gene function, regulation and control. Unknown gene sequences can be compared to databases of known genes to enable similarities to lead to determination of an unknown gene’s
  33. 33. PROTEOMICS Investigates patterns and levels of gene expression in diseased cells that can be analyzed to build databases of expression profiles.
  34. 34. PHARMACOGENOMICS Investigates SNPs and DNA mutations associated with disease susceptibility and drug sensitivities.
  35. 35. DEVELOPMENTALBIOLOGY Regulation of embryonic development. Regulation of the aging process.
  36. 36. EVOLUTIONARY ANDCOMPARATIVE BIOLOGY Because DNA mutates at a constant rate, comparisons of DNA between different organisms can provide evolutionary histories.
  37. 37. SUMMARY The significance of the completion of the human genome project cannot be overstated. With the dictionary of the genome available, the molecular mechanisms of human health and disease will be resolved. Armed with this knowledge a transformation in medical diagnostics and therapy is underway and will continue into the next few decades.
  38. 38. REFERENCES Cook-Deegan R (1989). "The Alta Summit, December 1984". G e no m ic s  5: 661–3. Barnhart, Benjamin J. (1989). "DOE Human Genome Program". Hum a n G e no m e Qua rte rly  1: 1. Retrieved 2005-02-03. DeLisi, Charles (2001). "Genomes: 15 Years Later A Perspective by Charles DeLisi, HGP Pioneer". Hum a n G e no m e N ws  11: 3–4. Retrieved e 2005-02-03.  International Human Genome Sequencing Consortium (2001). "Initial sequencing and analysis of the human genome." (PDF). N ture  409: 860– a 921.  Venter, JC, et al. (2001). "The sequence of the human genome." (PDF). Sc ie nc e  291: 1304–1351. Sanger F, Air GM, Barrell BG, e t a l.  (February 1977). "Nucleotide sequence of bacteriophage phi X174 DNA". N ture  265 (5596): 687–95. a Waterston RH, Lander ES, Sulston JE (2003). "More on the sequencing of the human genome". Pro c N tl A a d Sc i U S A 100: 3022–4. a c .
  39. 39. THANK YOU !